Clinical Trial Update: An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial of BMS-986165 in moderate-to-severe Crohn's disease was terminated, and results have been posted. The update provides the associated trial outco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• BMS-986165

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Granulomatous Colitis, Crohn's Disease | Phase 2 | Status: TERMINATED | Results posted: 2024-07-03